Abingworth Clinical Co-Development Fund 3 LP — Form D
Abingworth Clinical Co-Development Fund 3 LP of WASHINGTON, DC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-06-25. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-06-25
- Form: D
- Accession: 0002049495-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-549752
Issuer
- Name: Abingworth Clinical Co-Development Fund 3 LP
- CIK: 0002049495
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON, DC, 20004
- Phone: 202-729-5626
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jeremy Anderson | Executive Officer | Washington, DC |
| Christina Gibbs | Executive Officer | Washington, DC |
| David Lobe | Executive Officer | Washington, DC |
| Robert Rosen | Executive Officer | Washington, DC |
| N/A ACCD 3 GP LP | Promoter | Washington, DC |
| N/A ACCD 3 Holdings, L.L.C. | Promoter | Washington, DC |
More